The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Vellutan     (1S,3S,5Z)-5-[(2E)-2- [(1R,3aR,7aR)-1-[(2R...

Synonyms: Bonalfa, Curatoderm, tacalcitol, Apsor, Tacalcitolum, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Bonalfa

 

High impact information on Bonalfa

  • PRI-2191 alone had no effect on gene expression, but it enhanced the seizure-evoked expression of HSP-70, had an opposite effect on BDNF mRNA level and did not affect prepro-TRH mRNA level [4].
  • Summing up, the present study demonstrated that subchronic administration of PRI-2191 significantly modulated the seizure-related changes in both the brain and the peripheral immune system of rats [4].
  • An immunological study revealed that PRI-2191 reversed the seizure-induced decrease in the proliferative activity of splenocytes and their ability to produce interferon-gamma [4].
  • C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1 [5].
  • In addition, analogues PRI-1906 and PRI-2191 were screened against cells of human leukaemia HL-60 line and against normal human skin fibroblasts [6].
 

Gene context of Bonalfa

  • On the other hand, wortmannin did not affect the neuroprotective effects of 1,25 dihydroxyvitamin D(3) This suggests that the activation of PI3-K/Akt signaling pathway plays an important role in the mechanism of inhibitory action of PRI-2191 on hydrogen peroxide-evoked toxicity in SH-SY5Y cells [7].

References

  1. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191). Wietrzyk, J., Pełczyńska, M., Madej, J., Dzimira, S., Kuśnierczyk, H., Kutner, A., Szelejewski, W., Opolski, A. Steroids (2004) [Pubmed]
  2. Neuroprotective effects of (24R)-1,24-dihydroxycholecalciferol in human neuroblastoma SH-SY5Y cell line. Tetich, M., Kutner, A., Leskiewicz, M., Budziszewska, B., Lasoń, W. J. Steroid Biochem. Mol. Biol. (2004) [Pubmed]
  3. The rationale for deltanoids in therapy for myeloid leukemia: role of KSR-MAPK-C/EBP pathway. Studzinski, G.P., Wang, X., Ji, Y., Wang, Q., Zhang, Y., Kutner, A., Harrison, J.S. J. Steroid Biochem. Mol. Biol. (2005) [Pubmed]
  4. Effects of PRI-2191--a low-calcemic analog of 1,25-dihydroxyvitamin D3 on the seizure-induced changes in brain gene expression and immune system activity in the rat. Tetich, M., Dziedzicka-Wasylewska, M., Kuśmider, M., Kutner, A., Leśkiewicz, M., Jaworska-Feil, L., Budziszewska, B., Kubera, M., Myint, A.M., Basta-Kaim, A., Skowroński, M., Lasoń, W. Brain Res. (2005) [Pubmed]
  5. C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1. Astecker, N., Bobrovnikova, E.A., Omdahl, J.L., Gennaro, L., Vouros, P., Schuster, I., Uskokovic, M.R., Ishizuka, S., Wang, G., Reddy, G.S. Arch. Biochem. Biophys. (2004) [Pubmed]
  6. Antiproliferative activity in vitro of side-chain analogues of calcitriol against various human normal and cancer cell lines. Opolski, A., Wietrzyk, J., Chrobak, A., Marcinkowska, E., Wojdat, E., Kutner, A., Radzikowski, C. Anticancer Res. (1999) [Pubmed]
  7. Involvement of PI3-K in neuroprotective effects of the 1,25-dihydroxyvitamin D(3) analogue - PRI-2191. Regulska, M., Leśkiewicz, M., Budziszewska, B., Kutner, A., Basta-Kaim, A., Kubera, M., Jaworska-Feil, L., Lasoń, W. Pharmacological reports : PR (2006) [Pubmed]
 
WikiGenes - Universities